Zhang Qiu-Li, Wang Wei, Jiang Yan, Zhang Tian-Zi, Lu Zhan-Jun, Jiang Ao
Department of Ophthalmology, Affiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao 028000, the Inner Mongolia Autonomous Region, China.
Department of Ophthalmology, Tongliao Hospital, Tongliao 028000, the Inner Mongolia Autonomous Region, China.
Int J Ophthalmol. 2018 Mar 18;11(3):363-368. doi: 10.18240/ijo.2018.03.03. eCollection 2018.
To explore the concrete mechanism of a Mongolian compound medicine-Gurigumu-13 (GRGM) for glaucoma treatment.
DBA/2J mice, as glaucoma models, were intragastric administrated with GRGM to study the effect of GRGM on retinal ganglion cells (RGCs). The loss of RGCs was evaluated with the number of RGCs and axons. The expression of the target protein of RGCs or mouse retinas was determined by Western blot. The relative content of malondialdehyde (MDA) was examined by ELISA assay.
GRGM distinctly improved retina damage increasing the number of neurons, RGCs and axons in a concentration dependent manner. Meanwhile, GRGM obviously decreased the high level of MDA and the expression of oxidative stress-related proteins in retinas of DBA/2J mice, but promoted the expression of antioxidant proteins. Additionally, GRGM also significantly inhibited the protein expression of Bip and Chop, which were markers of endoplasmic reticulum stress-induced apoptosis.
GRGM have obvious protective effects on RGCs in DBA/2J mice, and increase the number of RGCs and axons inhibiting oxidative stress and endoplasmic reticulum stress.
探讨蒙药地格木-13(GRGM)治疗青光眼的具体机制。
以DBA/2J小鼠作为青光眼模型,对其进行GRGM灌胃,以研究GRGM对视网膜神经节细胞(RGCs)的影响。通过RGCs及其轴突的数量评估RGCs的损失情况。采用蛋白质免疫印迹法测定RGCs或小鼠视网膜靶蛋白的表达。采用酶联免疫吸附测定法检测丙二醛(MDA)的相对含量。
GRGM明显改善视网膜损伤,以浓度依赖方式增加神经元、RGCs和轴突的数量。同时,GRGM明显降低DBA/2J小鼠视网膜中高水平的MDA及氧化应激相关蛋白的表达,但促进抗氧化蛋白的表达。此外,GRGM还显著抑制内质网应激诱导凋亡的标志物Bip和Chop的蛋白表达。
GRGM对DBA/2J小鼠的RGCs具有明显的保护作用,通过抑制氧化应激和内质网应激增加RGCs和轴突的数量。